SEC Form 4 · accession 0001567619-15-001054
vTv Therapeutics Inc. · VTVT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey B Kindler
Officer — Executive Chairman · Director
Period of report
Aug 4, 2015
Accepted (ET)
Aug 5, 2015 · 9:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director stock option (right to buy)F1 | $15.00 | Aug 4, 2015 | A | 28,121 | A | — | Jul 29, 2025 | Class A common stock | 28,121 | 28,121 | D |
Explanation of responses
- F1The option vests in three equal annual installments beginning on July 29, 2016.